Selective class II HDAC inhibitors impair myogenesis by modulating the stability and activity of HDAC‐MEF2 complexes
- Type
- Expression of concern
- Notice date
- 11/26/2020 0:00
- Journal
- EMBO Reports
- Publisher
- EMBO Press
- Notice DOI
- 10.15252/embr.202051028
- Original paper DOI
- 10.1038/embor.2009.88